Healthcare -
Biotechnology - NASDAQ - US
$ 12.87
2.39 %
$ 169 M
Market Cap
-15.89
P/E
GLSI - STOCK-BASED COMPENSATION
Stock-based Compensation GLSI - Greenwich LifeSciences, Inc.
2.38 M
LAST VALUE
89.74%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR